OPKO Biologics presents preclinical data for acromegaly drug candidate

June 15, 2026 8:00 AM

OPKO Health Inc. (NASDAQ: OPK) subsidiary OPKO Biologics presented preclinical data for its drug candidate OPK8801001 at ENDO 2026, the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found